Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Regulatory News, In Brief

Jun 25 2012

• By Brenda Sandburg

Related Content

FDA Actions, In Brief

Apr 30 2012

K-V Gets FDA To Test Adequacy Of Makena’s Competing Compounded Products

Nov 08 2011

Pfizer’s <em>Vyndaqel </em>Splits Advisory Committee; Now It Must Move FDA

May 24 2012

Prevnar 13 Post-Market Trials Must Confirm Surrogate Endpoint, Deal With Immunogenicity

Jan 09 2012

ATLAS Trial Design Blamed For Missing Data On <em>Xarelto</em> ACS Use

Jun 04 2012

Related Companies

Pfizer Inc.

Merck & Co., Inc.

Alnylam Pharmaceuticals Inc.

Repligen Corp.

Alexza Pharmaceuticals, Inc.

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window